Details of the Drug
General Information of Drug (ID: DM5JHUN)
Drug Name |
CHROMOTROPATE
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
129-96-4; Chromotropic acid disodium salt; Sodium chromotropate; 2,7-Naphthalenedisulfonic acid, 4,5-dihydroxy-, disodium salt; Disodium chromotropate; Sodium 4,5-dihydroxynaphthalene-2,7-disulfonate; disodium 4,5-dihydroxynaphthalene-2,7-disulfonate; Disodium 4,5-dihydroxynaphthalene-2,7-disulphonate; Mordant Brown 7; Chromotropic acid sodium salt; 3888-44-6; 2,7-Naphthalenedisulfonic acid, 4,5-dihydroxy-, sodium salt (1:2); CHEMBL425511; 148-25-4 (Parent); CHROMOTROPATE; mordantbrown; Chromogen C; NSC 4883; EINECS 204-972-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 |
Molecular Weight | 364.3 | |||||||||||||||||||||
Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
Rotatable Bond Count | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count | 8 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||